久之洋跌2.01%，成交额7.91亿元，主力资金净流出703.65万元

Core Viewpoint - The stock of Jiuziyang has experienced significant fluctuations, with a notable increase in price over recent months, indicating strong market interest and potential growth in the company's financial performance [1][2]. Group 1: Stock Performance - As of January 7, Jiuziyang's stock price decreased by 2.01% to 83.69 CNY per share, with a trading volume of 7.91 billion CNY and a turnover rate of 5.17%, resulting in a total market capitalization of 150.64 billion CNY [1]. - Year-to-date, Jiuziyang's stock has risen by 3.71%, with a 17.46% increase over the last five trading days, a 47.45% increase over the last 20 days, and a remarkable 124.07% increase over the last 60 days [1]. Group 2: Financial Performance - For the period from January to September 2025, Jiuziyang reported a revenue of 357 million CNY, reflecting a year-on-year growth of 29.12%, while the net profit attributable to shareholders was 21.75 million CNY, up by 7.93% [2]. - Since its A-share listing, Jiuziyang has distributed a total of 217 million CNY in dividends, with 98.28 million CNY distributed over the past three years [3]. Group 3: Shareholder Information - As of December 31, the number of shareholders for Jiuziyang was 33,400, a decrease of 14.81% from the previous period, with an average of 5,388 circulating shares per shareholder, which is an increase of 17.39% [2]. - By September 30, 2025, Hong Kong Central Clearing Limited was the third-largest circulating shareholder, holding 1.1399 million shares, an increase of 586,900 shares from the previous period [3]. Group 4: Business Overview - Jiuziyang, established on April 27, 2001, and listed on June 2, 2016, is based in Wuhan, Hubei Province, specializing in the research, production, and sales of infrared thermal imaging cameras, laser rangefinders, and other related products [1]. - The company's main revenue sources include infrared thermal imaging cameras (55.88%), optical systems (28.62%), laser measurement and lighting products (14.81%), and other supplementary products (0.69%) [1].